戻る
Eli Lilly’s Orforglipron Success Navigates Complex GLP-1 Market Dynamics
戻る
株式ニュース
テーマ
Eli Lilly’s Orforglipron Success Navigates Complex GLP-1 Market Dynamics
Eli Lilly’s Orforglipron Success Navigates Complex GLP-1 Market Dynamics
Edgen Stock
·
Sep 08 2025, 08:09
共有先
共有先
リンクをコピー
ソース:
[1] Why weight-loss 'wonder drugs' aren't 'wonder stocks' — yet
[2] Eli Lilly eyes orforglipron approval after Phase III diabetes trial success
[3] Why obesity stocks are struggling in 2025? - Investing.com